FEATURES OF ADHERENCE TO TREATMENT OF YOUNG PERSONS WITH CARDIOVASCULAR DISEASES
Introduction: Cardiovascular diseases are an important medico-social problem and contribute greatly to public health. According to the World Health Organization, 17.1 million people die every year due to heart attack and stroke, and in recent years, it is more common in young people.
Aim: to study the features of adherence to treatment of young people with cardiovascular diseases.
Materials and methods: The study was randomly attended by patients with cardiovascular diseases aged 25-44 who were registered in medical institutions of Semey city. The research design is a cross-sectional study. Research methods: social, statistical. The choice of statistical criteria depends on the type of analyzed variables. Student's t-test and one-way ANOVA were used. A p value of less than 0.05 was considered significant. All analyzes were performed using IBM SPSS Statistics 25.
Research result: 294 patients with CVD between 25 and 44 years of age took part in the survey, their average age was 38.4 years. 105 (35.7%) men and 189 (64.3%) women participated. By nationality, 219 (74.5%) Kazakhs, 62 (21.1%) Russians and 13(4.4%) patients of other nationalities. According to the data of our study, 3 (1%) patients had a low level of adherence to treatment, 154 (52.4%) patients had an average level, and 137 (46.6%) patients showed a high level of adherence to treatment. Also, according to the types of adherence to treatment, many patients had an average degree.
Conclusion: Thus, features of adherence to treatment of young people with cardiovascular diseases were determined. According to age groups, in terms of overall adherence to treatment, emotional adherence to treatment and behavioral adherence to treatment in patients aged 25-40 years is lower than in patients aged 30-44 years. According to the status of young patients, workers and entrepreneurs had a lower level of adherence to treatment than others. In all types of adherence to treatment, patients who undergo regular medical check-up have higher adherence to treatment than patients who do not undergo regular medical check-up.
Gulbarshyn D. Mukasheva1, https://orcid.org/0000-0003-3490-5628
Tolkyn A. Bulegenov1, https://orcid.org/0000-0001-6145-9649
Nazarbek B. Omarov1, https://orcid.org/0000-0003-3262-1410
Sabit M. Zhussupov2, https://orcid.org/0000-0002-0551-126Х
Olga T. Van1
1 NJSC “Semey Medical University”, Semey, Republic of Kazakhstan;
2 Pavlodar branch of NCJSC «Semey Medical University», Pavlodar city, Republic of Kazakhstan.
1. Амлаев К.Р., Махов З.Д., Койчуева С.М., и др. Методы определения уровня и причины снижения приверженности лечению // Вестник Ставропольского государственного университета. 2012. №.3. С. 229-233.
2. Ахмедова З.М. Эпидемиология и социально-гигиенические аспекты сердечно-сосудистых заболеваний среди подростков Республики Дагестан: Дис. ...канд. мед. наук. – М., 2006. – 38 с.
3. ВОЗ. Сердечно-сосудистые заболевания. Информационный бюллетень 152 №317. Январь 2015 г.
4. Гуревич К.Г. Комплаенс больных, получающих гипотензивную терапию // Качественная клиническая практика. 2008. №.4. С. 53-58.
5. Доклад Генерального директора Всемирной организации здравоохранения (ВОЗ) – М. Чен. Международная конференция, посвященная 30-летию Алма-Атинской декларации по первичной медико-санитарной помощи. – Алматы, 2008. – 10 с.
6. Конради А.О. Артериальная гипертензия: как остановить эпидемию. Кардиоваскулярная терапия и профилактика. 2004;4:12-19.
7. Лутова Н.Б. Оценка факторов комплаентности психически больных и влияние на них коморбидных расстройств. – 2012. Методические указания. 23 с.
8. Мировой отчет по неинфекционным заболеваниям, 2010 г. – Женева, ВОЗ.
9. Самородская И.В. Сердечно-сосудистые заболевания: принципы статисти-ческого учета в разных странах // Здравоохранение. 2009. №7. С. 49-55.
10. Чазов Е.И., Оганов Р.Г., Погосова Г.В., и др. Депрессивная симптоматика ухудшает прогноз у больных артериальной гипертонией и ишемической болезнью сердца: первые результаты проспективного этапа российского многоцентрового исследования Координата // Кардиология. 2007;47:10: С. 24-30.
11. Anderson L., Taylor R.S. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews // Cochrane 197 Database Syst. Rev. 2014. Dec. 12. № 12. CD011273.
12. Byrd C.E. Understanding adherence to the typical anti-hypertensive treatment regimen: An expanded self-regulation theory based prediction model. – University of Florida, 2004. 190 с.
13. Chapman R.H., Benner J.S., Petrilla A.A.et al. Predictors of adherence with antihypertensive and lipid-lowering therapy // Archives of internal medicine. 2005. Vol. 165. №.10. P. 1147-1152.
14. Cífková R. et al. Blood pressure control and risk profile in poststroke survivors: a comparison with the general population //Journal of Hypertension. 2015. Vol. 33. №. 10. P. 2107-2114.
15. Fodor G.J., Kotrec M., Bacskai K. et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study //Journal of hypertension. 2005. Vol 23. №. 6. P. 1261-1266.
16. Hill M., Houston N. Adherence to antihypertensive therapy. 2007;131:390-392.
17. Jin J., Sklar, G.E., Oh V.M. et al. Factors affecting therapeutic compliance: A review from the patient’s perspective // Therapeutics and clinical risk management. 2008. Vol. 4. №. 1. P. 269.
18. Jokisalo E., Enlund H., Halonen P. et al. Factors related to poor control of blood pressure with antihypertensive drug therapy // Blood pressure. 2003. Vol. 12. №. 1. P. 49-55.
19. Kim M.T., Han H.R., Hill M.N. et al. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men // Ann Behav Med 2003; 26(1): P. 24-31.
20. Lehane E., McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper //International journal of nursing studies. 2007. Vol. 44. №. 8. P. 1468-1477.
21. Lowry K.P., Dudley T.K., Oddone E.Z. et al. Intentional and unintentional nonadherence to antihypertensive medication // Annals of Pharmacotherapy. 2005. Vol. 39. №. 7-8. P. 1198-1203.
22. Martín Alfonso L., Sairo Agramonte M., Bayarre Vea H. D. Frecuencia de cumplimiento del tratamiento médico en pacientes hipertensos // Revista Cubana de Medicina General Integral. 2003. Vol. 19. №. 2. P. 0-0.
23. McGinnis B., Olson K.L. et al. Dyslipidemia: factors related to adherence to statin therapy // Annals of Pharmacotherapy. 2007. Vol. 41. №. 11. P. 1805-1811.
24. Miklowitz D., George Е., Richards J., et al. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder // Archives of general psychiatry. 2003. Vol. 60. №. 9. P. 904-912.
25. Nunes M.I. The relationship between quality of life and adherence to treatment // Curr Hypertens Rep 2001; 3(6): P. 462-5.
26. Osterberg L., Blaschke T. Adherence to medication // New England journal of medicine. 2005. Vol. 353. №. 5. P. 487-497.
27. Perreault S., Lamarre, D., Blais, L. et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension // The Annals of pharmacotherapy. 2005. Vol. 39. №. 9. P. 1401-1408.
28. Ragot S., Sosner P., Bouche G. et al. Appraisal of the knowledge of hypertensive patients and assessment of the role of the pharmacists in the management of hypertension: results of a regional survey // Journal of human hypertension. 2005. Vol. 19. №.7. P. 577-584.
29. Sabate E. Adherence to long-term therapies: evidence for action. WHO, Geneva 2003. 209 p.
30. Salas M. et al. Impaired cognitive function and compliance with antihypertensive drugs in elderly: the Rotterdam Study // Clinical Pharmacology & Therapeutics. 2001. Vol. 70. №. 6. P. 561-566.
31. Schoberberger R., Janda M., Pescosta W. et al. The COMpliance Praxis Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medication //Journal of human hypertension. 2002. Vol. 16. №. 11. P 779-787.
32. Schroeder K., Fahey T., Ebrahim S. How can we improve adherence to blood pressure–lowering medication in ambulatory care?: systematic review of randomized controlled trials // Archives of internal medicine. 2004. Vol. 164. №.7. P. 722-732.
33. Sewitch M.J., Leffondré K., Dobkin P.L. Clustering patients according to health perceptions: relationships to psychosocial characteristics and medication nonadherence // Journal of psychosomatic research. 2004. Vol. 56. №.3. P. 323-332.
34. Svensson S., Kjellgren K.I., Ahlner J., et al. Reasons for adherence with antihypertensive medication // Int J Cardiol. 2000. 76(2-3): P. 157-63.
35. Werlemann B.C., Offers E., Kolloch R. Compliance problems in therapy resistant hypertension // Herz. 2004. Vol. 29. №. 3. P. 271-275.
References: [1-10]
1. Amlaev K.R., Makhov Z.D., Koichueva S.M., i dr. Metody opredeleniya urovnya i prichiny snizheniya priverzhennosti lecheniyu [Methods for determining the level and reasons for reducing adherence to treatment]. Vestnik Stavropol'skogo gosudarstvennogo universiteta [Bulletin of the Stavropol State University]. 2012. №.3. p. 229-233.
2. Akhmedova Z.M. Epidemiologiya i sotsial'no-gigienicheskie aspekty serdechno-sosudistykh zabolevanii sredi podrostkov Respubliki Dagestan [Epidemiology and socio-hygienic aspects of cardiovascular diseases among adolescents of the Republic of Dagestan]: Dis. ...kand. med. nauk. M., 2006. 38 p.
3. VOZ. Serdechno-sosudistye zabolevaniya [WHO. Cardiovascular diseases] Informatsionnyi byulleten' 152 N317. Yanvar' 2015 g.
4. Gurevich K.G. Komplaens bol'nykh, poluchayushchikh gipotenzivnuyu terapiyu [Compliance of patients receiving antihypertensive therapy]. Kachestvennaya klinicheskaya praktika [Qualitative clinical practice]. 2008. №.4. pp. 53-58.
5. Doklad General'nogo direktora Vsemirnoi organizatsii zdravookhraneniya (VOZ)[ Report of the Director-General of the World Health Organization. WHO] – M. Chen. Mezhdunarodnaya konferentsiya, posvyashchennaya 30-letiyu Alma-Atinskoi deklaratsii po pervichnoi mediko-sanitarnoi pomoshchi [nternational conference dedicated to the 30th anniversary of the Declaration of Alma-Ata on primary health care]. – Almaty, 2008. – 10 p.
6. Konradi A.O. Arterial'naya gipertenziya: kak ostanovit' epidemiyu [Arterial hypertension: how to stop the epidemic]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular therapy and prevention] 2004. 4:12-19.
7. Lutova N.B. Otsenka faktorov komplaentnosti psikhicheski bol'nykh i vliyanie na nikh komorbidnykh rasstroistv [Evaluation of compliance factors for mentally ill patients and the impact of comorbid disorders on them]. – 2012. Methodical instructions. 23 p.
8. Mirovoi otchet po neinfektsionnym zabolevaniyam, 2010 g. [World Report on Noncommunicable Diseases 2010] – Zheneva, VOZ.
9. Samorodskaya I.V. Serdechno-sosudistye zabolevaniya: printsipy statisti-cheskogo ucheta v raznykh stranakh [Cardiovascular diseases: principles of statistical accounting in different countries]. Zdravookhranenie [Health care]. 2009. №7. pp. 49-55.
10. Chazov E.I., Oganov R.G., Pogosova G.V., i dr. Depressivnaya simptomatika ukhudshaet prognoz u bol'nykh arterial'noi gipertoniei i ishemicheskoi bolezn'yu serdtsa: pervye rezul'taty prospektivnogo etapa rossiiskogo mnogotsentrovogo issledovaniya Koordinata [Depressive symptoms worsen prognosis in patients with arterial hypertension and coronary heart disease: first results of a prospective stage of the Russian multicenter study Coordinata]. Kardiologiya [Cardiology]. 2007. 47:10: P. 24-30.
Number of Views: 125
Category of articles:
Original articles
Bibliography link
Mukasheva G.D., Bulegenov T.A., Omarov N.B., Zhussupov S.M., Van O.T. Features of adherence to treatment of young persons with cardiovascular diseases // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 4, pp. 115-124. doi 10.34689/SH.2022.24.4.015Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS